Meibomian Gland Probing: Restoring Blocked Oil Glands to Treat Chronic Dry Eye Disease

For millions of people suffering from chronic dry eye disease, traditional treatments such as artificial tears, warm compresses, eyelid hygiene, omega-3 supplements, and prescription eye drops often provide only temporary relief. The underlying problem frequently remains untreated—obstruction of the meibomian glands.

Meibomian gland dysfunction (MGD) is now recognized as the leading cause of evaporative dry eye disease worldwide. When these specialized oil-producing glands become obstructed, the tear film becomes unstable, tears evaporate rapidly, and inflammation develops across the ocular surface.

One of the most innovative treatments developed to directly address gland obstruction is intraductal meibomian gland probing (MGP). Unlike therapies that heat or express the glands externally, probing physically restores the natural opening of blocked glands from within.

Understanding Meibomian Gland Dysfunction

Healthy meibomian glands continuously secrete meibum, a lipid that forms the outermost layer of the tear film. This oil slows tear evaporation, improves visual quality, and protects the ocular surface.

In obstructive MGD, several changes occur:

• Thickened meibum blocks gland openings.

• Chronic inflammation narrows gland ducts.

• Fibrotic tissue may develop around the ducts.

• Pressure builds within the glands.

• Oil secretion decreases.

• Glands gradually become damaged or atrophic.

As gland obstruction worsens, patients experience:

• Burning eyes

• Foreign body sensation

• Fluctuating vision

• Contact lens intolerance

• Light sensitivity

• Excessive tearing

• Chronic eyelid inflammation

Simply heating the glands may not completely relieve obstruction when fibrotic narrowing is present.

What Is Meibomian Gland Probing?

Meibomian gland probing is an in-office procedure in which a very fine stainless-steel probe is gently inserted through the natural gland opening after topical anesthesia.

The goal is to:

• Restore ductal patency

• Release fixed intraductal obstruction

• Reduce intraglandular pressure

• Improve meibum flow

• Preserve viable glands

• Improve tear film stability

Many patients describe immediate pressure relief following treatment, particularly when glands have been chronically obstructed.

Why Probing Is Different

Most conventional MGD therapies work from the outside in.

Examples include:

• Warm compresses

• Thermal pulsation

• Intense Pulsed Light (IPL)

• Radiofrequency

• Manual gland expression

These treatments soften meibum and reduce inflammation but may not fully address fixed ductal obstruction.

Probing works from the inside out, mechanically reopening the gland's natural drainage pathway before additional therapies optimize gland function.

For many specialists, probing is viewed as one component of a comprehensive treatment plan rather than a standalone cure.

Which Patients May Benefit?

Meibomian gland probing may be considered for patients with:

• Chronic obstructive MGD

• Persistent dry eye despite conventional treatment

• Reduced meibomian gland secretion

• Lid tenderness

• Ocular rosacea

• Recurrent chalazia

• Significant gland obstruction on meibography

• Patients who plateau after IPL or thermal pulsation

• Past or present use of Accutane

Careful evaluation with slit-lamp examination, meibography, gland expression, and tear film testing helps determine candidacy.

Combining Probing with Other Modern Treatments

Many dry eye specialists combine probing with additional therapies to maximize long-term outcomes.

These may include:

• Intense Pulsed Light (IPL)

• Radiofrequency

• Thermal pulsation

• BlephEx®

• ZEST® eyelid debridement

• Optivize

• Demodex treatment

• Prescription anti-inflammatory medications

• Omega-3 supplementation

• Advanced eyelid hygiene

Restoring gland patency first may improve the effectiveness of subsequent therapies in selected patients.

What Does the Research Show?

The scientific literature surrounding meibomian gland probing has grown steadily over the past decade. Published studies have reported improvements in:

• Dry eye symptoms

• Ocular Surface Disease Index (OSDI)

• Tear break-up time (TBUT)

• Meibomian gland secretion

• Lid tenderness

• Lid margin inflammation

• Patient quality of life

Several studies have demonstrated statistically significant symptom improvement in patients whose disease had not responded adequately to conventional therapy. 

Is Meibomian Gland Probing Safe?

Published studies have generally reported a favorable safety profile when the procedure is performed by experienced clinicians using appropriate technique. Most patients experience only temporary tenderness or mild irritation that resolves within a short period. 

A Personalized Approach to Dry Eye Care

No single treatment is effective for every patient with dry eye disease. Meibomian gland dysfunction is a multifactorial condition that often requires a combination of therapies tailored to the individual.

For patients with persistent gland obstruction despite conventional treatment, meibomian gland probing may provide an additional option aimed at restoring gland function rather than simply managing symptoms.

A comprehensive evaluation by a dry eye specialist—including meibography, tear film analysis, and assessment of eyelid inflammation—can help determine whether meibomian gland probing should be part of an individualized treatment plan.

Top 5 Peer-Reviewed Studies Supporting Meibomian Gland Probing

1. Maskin SL. Intraductal Meibomian Gland Probing Relieves Symptoms of Obstructive Meibomian Gland Dysfunction. Cornea. 2010.

   • First clinical report describing intraductal probing.

   • Significant symptom improvement in patients with obstructive MGD.

   • Introduced the concept of relieving fixed intraductal obstruction. (PMC)

2. Kheirkhah A, et al. A Randomized, Sham-Controlled Trial of Intraductal Meibomian Gland Probing With or Without Topical Antibiotic/Steroid for Obstructive Meibomian Gland Dysfunction. Cornea. 2020.

   • Randomized, double-masked, sham-controlled clinical trial.

   • Demonstrated significant improvement in patient-reported dry eye symptoms after probing, particularly in refractory MGD. (PubMed)

3. Maskin SL. Intraductal Meibomian Gland Probing: Background, Patient Selection, Procedure, and Perspectives. Clinical Ophthalmology. 2019.

   • Comprehensive review of the procedure, patient selection, mechanism of action, and published outcomes.

   • Summarizes evidence from multiple independent studies across several countries. (PMC)

4. Warren NA, Maskin SL. Review of Literature on Intraductal Meibomian Gland Probing with Insights from the Inventor and Developer: Fundamental Concepts and Misconceptions. Clinical Ophthalmology. 2023.

   • Reviews more than a dozen peer-reviewed studies.

   • Discusses indications, outcomes, safety, and common misconceptions while highlighting the need for continued high-quality research. (PubMed)

5. Ahmed A, et al. Intraductal Meibomian Gland Probing and Its Efficacy in the Treatment of Meibomian Gland Dysfunction. Survey of Ophthalmology. 2020.

   • Independent review of the available evidence.

   • Concludes that probing is a promising treatment for obstructive MGD while emphasizing the importance of further randomized, long-term studies. (ScienceDirect)

These studies collectively support meibomian gland probing as a promising treatment for selected patients with obstructive MGD, particularly those who have not responded adequately to conventional therapies.